| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3877577 | The Journal of Urology | 2005 | 5 Pages |
Abstract
In addition to pathological stage and tumor grade, LVI is an independent prognostic factor for disease specific survival in upper tract TCC. Patients in the high and/or intermediate risk groups may benefit from integrated therapies with surgery and postoperative systemic chemotherapy.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
EIJI KIKUCHI, YUTAKA HORIGUCHI, JUN NAKASHIMA, NAOKI HATAKEYAMA, MAYUKO MATSUMOTO, TORU NISHIYAMA, MASARU MURAI,